Kuraray (3405) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
13 May, 2026Executive summary
Net sales rose to ¥200.9 billion (3.1% year-over-year) in Q1 FY2026, but operating income fell by ¥3.8 billion to ¥14.9 billion and net income attributable to owners dropped 35.0% to ¥7.8 billion.
Ordinary income and net income attributable to owners also declined year-over-year.
Economic uncertainty increased due to Middle East instability, impacting raw material procurement and logistics.
Organizational reform shifted Electronics Materials Promotion Division from "Others" to "Functional Materials" segment.
Financial highlights
Net sales: ¥200.9 billion (up ¥6.1 billion or 3.1% year-over-year).
Operating income: ¥14.9 billion (down ¥3.8 billion or 20.3% year-over-year).
Ordinary income: ¥13.7 billion (down ¥4.1 billion or 22.9% year-over-year).
Net income attributable to owners: ¥7.8 billion (down ¥4.2 billion or 35.0% year-over-year).
EPS for Q1 2026 was ¥25.62, down from ¥37.07 in Q1 2025.
Outlook and guidance
FY2026 full-year net sales forecast: ¥850.0 billion, up ¥41.6 billion or 5.1% from FY2025.
Operating income forecast: ¥70.0 billion, up ¥11.1 billion or 18.9% year-over-year.
Net income attributable to owners forecast: ¥40.0 billion, up 435.6% year-over-year.
No revision to consolidated earnings forecast due to ongoing uncertainties in the Middle East.
Latest events from Kuraray
- FY2025 profit dropped on impairments, but FY2026 forecasts a strong rebound and higher dividends.3405
Q4 202610 Feb 2026 - SentryGlas® dominates structural glass with high performance and sustainability, driving global growth.3405
Investor Update19 Dec 2025 - Profits fell over 50% year-over-year; forecasts cut and major share buyback completed.3405
Q3 202612 Nov 2025 - Profits and sales fell in 1H FY2025, but portfolio restructuring and buybacks advanced.3405
Q2 20268 Aug 2025 - High-performance PVOH products and cell culture solutions drive robust global growth outlook.3405
Investor Day 202519 Jun 2025 - Profits and shareholder returns rose, with robust guidance despite lower sales forecast.3405
Q3 202513 Jun 2025 - Record interim results and upgraded outlook, with increased dividends and share buybacks.3405
Q2 202513 Jun 2025 - Sales up, profits down; full-year outlook steady, major share buyback planned.3405
Q1 20266 Jun 2025 - Record sales and operating income, but net income fell on extraordinary losses; profit recovery forecast.3405
Q4 20255 Jun 2025